IMS MAXIMS Announced as Finalist in HealthInvestor Awards

IMS MAXIMSIMS MAXIMS has announced that it has been shortlisted as a finalist in the 'Technology provider of the year' category for the HealthInvestor Awards 2013. The prestigious HealthInvestor awards recognise innovation in the healthcare sector and celebrate excellence in a wide range of categories from complex care provider of the year to diagnostics provider of the year. In each of the 22 categories an independent panel of high profile judges will look for organisations and individuals that have made an outstanding contribution to healthcare throughout 2012.

IMS MAXIMS has been shortlisted for the award after the company demonstrated numerous initiatives and partnerships aimed at improving the quality of patient care, increasing efficiency and enhancing the uptake of healthcare IT across the health service.

Among the initiatives was the launch of the Electronic Patient Information Centre (E.P.I.Centre) campaign, which aims to promote innovation across health and social care through the development of a physical and virtual centre to share best practice around healthcare technology.

In addition, IMS MAXIMS announced a 'first of its kind' partnership with St Helen’s and Knowsley Teaching Hospitals NHS Trust, to offer the NHS a fully integrated electronic patient record solution hosted within an NHS trust.

Shane Tickell, CEO of IMS MAXIMS said: "Being shortlisted as a finalist in the 'Technology provider of the year' category is testament to the hard work of the IMS MAXIMS team in thinking outside the box to deliver agile solutions that meet the needs of the healthcare service.

"IMS MAXIMS prides itself on its responsiveness and ability to tailor its solutions to the individual needs of healthcare organisations as well as having a deep understanding of how technology can help address much wider issues. We very much look forward to the awards ceremony in June."

During 2012, IMS MAXIMS also began the development of its Da Vinci product, a cloud-based electronic health record for patients that will be supplemented by a number of mobile apps to give patients ownership and responsibility for their health record, potentially removing the need for hospitals to store such information on their own systems. IMS MAXIMS' innovative nature has been well recognised by a number of multinational corporations, recently resulting in securing a partnership with a global IT vendor.

Other key highlights include deploying full electronic patient record system to local charity, CancerCare, to support its staff and patients, as well as working alongside an NHS hospital trust to deploy the dementia system in order to help the trust diagnose and more efficiently treat patients with dementia, meanwhile meeting CQUIN requirements and payments.

The winners of the HealthInvestor Awards will be announced at a black-tie dinner at the Grosvenor House Hotel, Park Lane, London on Wednesday 12 June.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...